Related Experiment Videos
An autoantibody profile in primary sclerosing cholangitis
D Zauli1, E Schrumpf, C Crespi
1Istituto di Clinica Medica II, University of Bologna, Italy.
Journal of Hepatology
|August 1, 1987
Summary
Patients with primary sclerosing cholangitis (PSC) exhibit a high prevalence of various autoantibodies, particularly IgM and homogenous antinuclear antibodies, suggesting a role for immunological factors in this autoimmune liver disease.
Area of Science:
- Immunology
- Gastroenterology
- Autoimmune Diseases
Background:
- Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with an unknown etiology.
- Autoimmune factors are suspected to play a role in the pathogenesis of PSC.
Purpose of the Study:
- To investigate the prevalence and types of autoantibodies in patients with PSC.
- To compare autoantibody profiles in PSC patients with healthy controls and patients with inflammatory bowel disease.
Main Methods:
- Serum samples from PSC patients, healthy controls, and inflammatory bowel disease patients were analyzed.
- Various autoantibodies, including antinuclear antibodies (ANA), were detected and quantified.
Main Results:
- A significantly higher frequency and elevated titers of autoantibodies were observed in PSC patients compared to controls.
- The homogenous type of ANA was the most prevalent, found in 35% of PSC patients overall and 67% of female patients.
- Most detected antibodies were of the IgM isotype, with no correlation found between autoantibody positivity and clinical parameters.
Conclusions:
- The findings support the hypothesis that immunological factors, indicated by the presence of specific autoantibodies, are relevant in the pathogenesis of PSC.
- Autoantibody profiling may offer insights into the autoimmune basis of PSC.